Cite

HARVARD Citation

    Chaparro, M. et al. (2019). Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. 1380-1386. [Online]. 
  
Back to record